Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
if timeline of mayo dress rehearsal to actual live test resembles the rabbit vx-2 at JHU, then yes, strongly agree, human could be easily already lined up and awaiting completion of dress rehearsal.
is it stupid to post that I have added shares this week, and won't be risking any from hereon?
and if I I just bought and held for the last six years, I would only have 160k shares. now I have over a 1.2mill. so, yeah... thanks for the advice
transparency is what makes us better as a group, thanks for the feedback.
playing with fire, I got lucky today. sold small @.064, bought them back @.055
working with Eckert and Ziegler to produce isotopes, India, France, Czech Republic, Belgium, Brazil, Germany x2 and. U$ x2. Georgia and California
at some point isopet will be standing on its own legs financially. I would be surprised if not already.
couldn't agree more.
you must know that posting a timeline is a horrible plan if you seek organic growth in you stock value.
"animal tumors are a lot like human tumors". author unknown
Bengals and Niners. pick two. I will give all who respond today $100 at vegas party
all the talk about technical procedures being finalized and QMS being polished, sure gives the perception that the doc is readying radiogel for a "turnkey" turnover to a new owner?
the fact that isopet treatment can be covered by pet insurance is a huge "below the surface iceburg" factor. insurers aren't generally too receptive to paying for treatments that don't work, or are too expensive.
Enen though the wait is painful, I think we will all benefit from organic growth in value.
I've never used the covid window as an excuse. but if the virus did actually kill our chemist, then is that not a covid related hurdle. I enjoy a good debate, but I've never persued covid as a talking point. don't use it against me when commenting on my posts or I will use facts to refute your claims.
partially true. depends on how you want to see the half-filled glass of water. were the "random" animal treatments for FDA benefit, or for internal data used to further develope product? Or both?
anyone who claims that time spent on developing isopet is a waste. they are only speaking of $$. the time spent was a. necessary- to to develop data clusters about the gel in living tissue, and b. may actually start turning into revenue stream soon to help fund the radiogel side of business. this may help lengthen the "runway". -author unknown to you,. but we shall call him malibew.
I visited exubrion website "collaboration". the potential outside of cancer is, IMO, potentially , smoke coming out of my earholes. the math cannot be completed at this time. Help me. Osteoarthritis alone. just go to exubrion and watch the video...
all due respect, but recent ihub predictions of acclerated timeline seem to be a setup for a bearish barrage.
January/February IDE application should not be expected unless it is PR'd.
the comment was in the original post, it has not been recently added. I remember reading it.
IMO slow methodical progress =organic, sustained price that reflects actual value. not what some here are hoping for.
the constant posts about wasting $$millions and years... pull the string, "there's a snake in my boot". this isn't a deep pocket company that can fast track the process. years spent gathering real data on a budget. we are all going to be better off by being patient.
truth, we are as close as we have ever been to IDE submission. truth,. FDA is assisting us with hand holding. truth, it is taking longer than we all would like.
all due respect, but if you read the words as written, "has let them acclimate for the required two weeks" . this is not a future looking statement. it is past tense. already happened. history. done. no longer required. etc, etc.
recap and PR in the morning.
varian has acquired sirtex. interstingly, varian has a very nice imagery machine, sounds like a great partner to have. google hypersight
19 hours ahead.
and the timing of the post would have been at 2-3am if they were at their home office. what time is it in Australia, when 2am PST.?
Miley-Cyrus and Dolly lit it up
It's true, we do not know what the future holds. But, I certainly am not going to be caught without my shares.
Twitter headline has been there for a while. I don't think it is an attempt at being bold. I think it is strictly for clarification of the diffetence between branding names.
you're correct. having your company name associated with a vet school is not a big deal. I have never even heard of JHU. I'de rather see SNHU.
let's fond out right now. 1.3 mil for me
as with all government agencies that require inspection/approval, we have to appease them with that data they want, despite the relevance. FDA is the authority, but Dr Fischer and Korenko are the experts. perhaps the doctors are doing the hand holding to ensure FDA comfort.
a man with Dr. Korenko's educational and professional resume does not just throw money away to prop up a company at his age.
I wouldn't call a $5k buy in, chump change.
thanks for the clarification stock101. I know that my post was lengthy, but "drawn out"? hahaha. thanks.
IDE SUBMISSION=I think we see minimal movement, because the data from final rabbit test may not be publically revealed. So Submission may appear to be "blind submission". .07-.08
IDE APPROVAL=now we see action. we skip the booster rocket stage, and go straight to 100million market cap. .20-.30 range
HUMAN TRIALS=.30 - BUYOUT ($1-$2)
the monday selloff was definitely a retailer. my guess is someone one this forum who has a ton of shares and losing patience, but not confidence. trying to stimulate volume, my guess only.
is anyone else here Bullish?